Real-time enrollment status for this advanced solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:27 PM UTC
| NCT Number | NCT07356453 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 8 sites in the US |
| Sponsor | FoRx Therapeutics AG |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of August 28, 2026: Clinical trial NCT07356453 is currently recruiting participants. This phase1 study for advanced solid tumors is actively seeking new participants at 8 locations across the United States. The study is sponsored by FoRx Therapeutics AG. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07356453 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07356453 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.